首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1402205

全球體外肺模型市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

Global In Vitro Lung Model Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年12月01日 | 出版商:

Value Market Research | 英文 174 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2030 年，全球體外肺模型市場的市場規模將從 2022 年的 336.66 萬美元達到近 1,290.54 萬美元，2023-2030 年研究期間的CAGR為 18.29%。

體外肺模型是為了在活體之外進行研究、藥物開發和測試目的而創建的人類肺的人工表示或模擬。這些模型複製了肺結構和功能的某些方面，以研究呼吸生理學、疾病、藥物反應和毒理學。

市場動態

氣喘和慢性阻塞性肺病等呼吸系統疾病的流行推動了體外肺模型市場的成長，這需要可靠的研究模型。體外肺模型提供了一個受控環境來研究疾病機制、藥物反應和潛在的治療方法，滿足了對有效解決方案不斷成長的需求。製藥業嚴重依賴這些模型來加快藥物開發和呼吸系統疾病測試，減少對動物測試的依賴並簡化藥物交互作用和毒性的評估。此外，隨著個人化醫療的發展，體外肺模型對於預測個別患者對治療的反應至關重要，有助於開發標靶治療。組織工程和 3D 列印等技術進步提高了這些模型的準確性和複雜性，增強了它們與實際肺組織和功能的相似性。此外，減少動物試驗的監管壓力和吸入毒理學研究的進步進一步推動了體外肺模型的採用。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球體外肺模型市場的各個細分市場進行了包容性評估。體外肺模型產業的成長和趨勢為這項研究提供了整體方法。

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲體外肺模型市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。體外肺模型市場的主要參與者包括 Epithelix、MATTEK、Lonza、Emulate、AlveoliX AG、Nortis、CN Bio Innovations Ltd、MIMETAS、InSphero、ATTC Global。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：體外肺模型公司的競爭格局

體外肺部模型市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Epithelix

公司簡介
公司收入
產品
最近的發展

MATTEK

公司簡介
公司收入
產品
最近的發展

Lonza

公司簡介
公司收入
產品
最近的發展

Emulate

公司簡介
公司收入
產品
最近的發展

AlveoliX AG

公司簡介
公司收入
產品
最近的發展

Nortis

公司簡介
公司收入
產品
最近的發展

CN Bio Innovations Ltd

公司簡介
公司收入
產品
最近的發展

MIMETAS

公司簡介
公司收入
產品
最近的發展

InSphero

公司簡介
公司收入
產品
最近的發展

ATTC Global

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113159

The global demand for In Vitro Lung Model Market is presumed to reach the market size of nearly USD 1290.54 MN by 2030 from USD 336.66 MN in 2022 with a CAGR of 18.29% under the study period 2023 - 2030.

An in vitro lung model is an artificial representation or simulation of the human lung created for research, drug development, and testing purposes outside of a living organism. These models replicate certain aspects of lung structure and function to study respiratory physiology, diseases, drug responses, and toxicology.

MARKET DYNAMICS

The in vitro lung model market growth is fueled by the increasing prevalence of respiratory diseases like asthma and COPD, which necessitates reliable research models. In vitro lung models provide a controlled environment to study disease mechanisms, drug responses, and potential treatments, catering to the rising demand for effective solutions. Pharmaceutical industries heavily rely on these models to expedite drug development and testing for respiratory conditions, reducing reliance on animal testing and streamlining the assessment of drug interactions and toxicity. Additionally, as personalized medicine gains traction, in vitro lung models are vital in predicting individual patient responses to treatments, aiding in the development of targeted therapies. Technological advancements, including tissue engineering and 3D printing, enhance the accuracy and sophistication of these models, augmenting their resemblance to actual lung tissue and function. Moreover, regulatory pressures to reduce animal testing and advancements in inhalation toxicology studies further drive the adoption of in vitro lung models.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vitro lung model. The growth and trends of in vitro lung model industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the in vitro lung model market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

2D Model
3D Model

By Application

Drug Discovery & Toxicology Studies
Physiological Research
3D Model Development
Others

By End-Use

Academic Research Institutes
Pharmaceutical & Biotechnology Companies
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In Vitro Lung Model market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In Vitro Lung Model market include Epithelix, MATTEK, Lonza, Emulate, AlveoliX AG, Nortis, CN Bio Innovations Ltd, MIMETAS, InSphero, ATTC Global. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . IN VITRO LUNG MODEL - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 2D Model Historic and Forecast Sales by Regions
5.5 3D Model Historic and Forecast Sales by Regions

6 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Drug Discovery & Toxicology Studies Historic and Forecast Sales by Regions
6.5 Physiological Research Historic and Forecast Sales by Regions
6.6 3D Model Development Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY END-USE

7.1 Overview by End-use
7.2 Historical and Forecast Data
7.3 Analysis by End-use
7.4 Academic Research Institutes Historic and Forecast Sales by Regions
7.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE IN VITRO LUNG MODEL COMPANIES

9.1. In Vitro Lung Model Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF IN VITRO LUNG MODEL INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Epithelix
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. MATTEK
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Lonza
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Emulate
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. AlveoliX AG
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Nortis
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. CN Bio Innovations Ltd
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. MIMETAS
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. InSphero
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. ATTC Global
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments